Advertisement
Research Article| Volume 306, ISSUE 1-2, P82-90, July 15, 2011

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures

      Abstract

      Background

      Neuromyelitis optica (NMO, Devic disease) is a severely disabling autoimmune disorder of the CNS, which was considered a subtype of multiple sclerosis (MS) for many decades. Recently, however, highly specific serum autoantibodies (termed NMO-IgG or AQP4-Ab) have been discovered in a subset (60–80%) of patients with NMO. These antibodies were subsequently shown to be directly involved in the pathogenesis of the condition. AQP4-Ab positive NMO is now considered an immunopathogenetically distinct disease in its own right. However, to date little is known about the cerebrospinal fluid (CSF) in AQP4-Ab positive NMO.

      Objective

      To describe systematically the CSF profile of AQP4-Ab positive patients with NMO or its formes frustes, longitudinally extensive myelitis and optic neuritis.

      Material and methods

      Cytological and protein biochemical results from 211 lumbar punctures in 89 AQP4-Ab positive patients of mostly Caucasian origin with neuromyelitis optica spectrum disorders (NMOSD) were analysed retrospectively.

      Results

      CSF-restricted oligoclonal IgG bands, a hallmark of MS, were absent in most patients. If present, intrathecal IgG (and, more rarely, IgM) synthesis was low, transient, and, importantly, restricted to acute relapses. CSF pleocytosis was present in around 50% of samples, was mainly mild (median, 19 cells/μl; range 6–380), and frequently included neutrophils, eosinophils, activated lymphocytes, and/or plasma cells. Albumin CSF/serum ratios, total protein and CSF L-lactate levels correlated significantly with disease activity as well as with the length of the spinal cord lesions in patients with acute myelitis. CSF findings differed significantly between patients with acute myelitis and patients with acute optic neuritis at the time of LP. Pleocytosis and blood CSF barrier dysfunction were also present during remission in some patients, possibly indicating sustained subclinical disease activity.

      Conclusion

      AQP4-Ab positive NMOSD is characterized by CSF features that are distinct from those in MS. Our findings are important for the differential diagnosis of MS and NMOSD and add to our understanding of the immunopathogenesis of this devastating condition.

      Abbreviations:

      AQP4 (aquaporin-4), AQP4-Ab (aquaporin-4 antibody), CBA (cell based assay), CSF (cerebro-spinal fluid), IHC (immunohistochemistry), LETM (longitudinally extensive transverse myelitis), LP (lumbar puncture), NMO (neuromyelitis optica), NMOSD (neuromyelitis optica spectrum disorders), NMO-IgG (neuromyelitis optica immunoglobulin G), OCB (oligoclonal bands), QAlb (albumin CSF/serum ratio), QIgG (IgG CSF/serum ratio), QIgM (IgM CSF/serum ratio), QIgA (IgA CSF/serum ratio), rON (recurrent optic neuritis)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wingerchuk D.M.
        • Hogancamp W.F.
        • O'Brien P.C.
        • Weinshenker B.G.
        The clinical course of neuromyelitis optica (Devic's syndrome).
        Neurology. 1999; 53: 1107-1114
        • Jarius S.
        • Franciotta D.
        • Bergamaschi R.
        • Wright H.
        • Littleton E.
        • Palace J.
        • et al.
        NMO-IgG in the diagnosis of neuromyelitis optica.
        Neurology. 2007; 68: 1076-1077
        • Lennon V.A.
        • Kryzer T.J.
        • Pittock S.J.
        • Verkman A.S.
        • Hinson S.R.
        IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.
        J Exp Med. 2005; 202: 473-477
        • Lennon V.A.
        • Wingerchuk D.M.
        • Kryzer T.J.
        • Pittock S.J.
        • Lucchinetti C.F.
        • Fujihara K.
        • et al.
        A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
        Lancet. 2004; 364: 2106-2112
        • Paul F.
        • Jarius S.
        • Aktas O.
        • Bluthner M.
        • Bauer O.
        • Appelhans H.
        • et al.
        Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
        PLoS Med. 2007; 4: e133
        • Jarius S.
        • Paul F.
        • Franciotta D.
        • Waters P.
        • Zipp F.
        • Hohlfeld R.
        • et al.
        Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
        Nat Clin Pract Neurol. 2008; 4: 202-214
        • Jarius S.
        • Wildemann B.
        AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.
        Nat Rev Neurol. 2010; 6: 383-392
        • Bradl M.
        • Misu T.
        • Takahashi T.
        • Watanabe M.
        • Mader S.
        • Reindl M.
        • et al.
        Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
        Ann Neurol. 2009; 66: 630-643
        • Bennett J.L.
        • Lam C.
        • Kalluri S.R.
        • Saikali P.
        • Bautista K.
        • Dupree C.
        • et al.
        Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.
        Ann Neurol. 2009; 66: 617-629
        • Kinoshita M.
        • Nakatsuji Y.
        • Kimura T.
        • Moriya M.
        • Takata K.
        • Okuno T.
        • et al.
        Neuromyelitis optica: passive transfer to rats by human immunoglobulin.
        Biochem Biophys Res Commun. 2009; 386: 623-627
        • Kinoshita M.
        • Nakatsuji Y.
        • Kimura T.
        • Moriya M.
        • Takata K.
        • Okuno T.
        • et al.
        Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells.
        Biochem Biophys Res Commun. 2010; 394: 205-210
        • Saadoun S.
        • Waters P.
        • Bell B.A.
        • Vincent A.
        • Verkman A.S.
        • Papadopoulos M.C.
        • et al.
        Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
        Brain. 2010; 133(Pt2): 349-361
        • Bergamaschi R.
        Importance of cerebrospinal fluid examination in differential diagnosis of Devic's neuromyelitis optica by multiple sclerosis.
        Neurol Sci. 2003; 24: 95-96
        • Bergamaschi R.
        • Tonietti S.
        • Franciotta D.
        • Candeloro E.
        • Tavazzi E.
        • Piccolo G.
        • et al.
        Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations.
        Mult Scler. 2004; 10: 2-4
        • Piccolo G.
        • Franciotta D.M.
        • Camana C.
        • Bergamaschi R.
        • Banfi P.
        • Sandrini G.
        • et al.
        Devic's neuromyelitis optica: long-term follow-up and serial CSF findings in two cases.
        J Neurol. 1990; 237: 262-264
        • Zaffaroni M.
        Cerebrospinal fluid findings in Devic's neuromyelitis optica.
        Neurol Sci. 2004; 25: S368-S370
        • Nakamura M.
        • Nakashima I.
        • Sato S.
        • Miyazawa I.
        • Fujihara K.
        • Itoyama Y.
        Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands.
        Mult Scler. 2007; 13: 332-335
        • Jarius S.
        • Franciotta D.
        • Paul F.
        • Ruprecht K.
        • Bergamaschi R.
        • Rommer P.S.
        • et al.
        Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance.
        J Neuroinflammation. 2010; 7: 52
        • Wingerchuk D.M.
        • Lennon V.A.
        • Pittock S.J.
        • Lucchinetti C.F.
        • Weinshenker B.G.
        Revised diagnostic criteria for neuromyelitis optica.
        Neurology. 2006; 66: 1485-1489
        • Weinshenker B.G.
        • Wingerchuk D.M.
        • Vukusic S.
        • Linbo L.
        • Pittock S.J.
        • Lucchinetti C.F.
        • et al.
        Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.
        Ann Neurol. 2006; 59: 566-569
        • Jarius S.
        • Probst C.
        • Borowski K.
        • Franciotta D.
        • Wildemann B.
        • Stoecker W.
        • et al.
        Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen.
        J Neurol Sci. 2010; 291: 52-56
        • Andersson M.
        • Alvarez-Cermeno J.
        • Bernardi G.
        • Cogato I.
        • Fredman P.
        • Frederiksen J.
        • et al.
        Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
        J Neurol Neurosurg Psychiatry. 1994; 57: 897-902
        • Reiber H.
        Cerebrospinal fluid—physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases.
        Mult Scler. 1998; 4: 99-107
        • Reiber H.
        Flow rate of cerebrospinal fluid (CSF)—a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases.
        J Neurol Sci. 1994; 122: 189-203
        • Reiber H.
        • Teut M.
        • Pohl D.
        • Rostasy K.M.
        • Hanefeld F.
        Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid.
        Mult Scler. 2009; 15: 1466-1480
        • Franciotta D.
        • Jarius S.
        • Aloisi F.
        More on multiple sclerosis and neuromyelitis optica.
        Arch Neurol. 2007; 64 (author reply-3): 1802
        • Weinshenker B.G.
        Neuromyelitis optica is distinct from multiple sclerosis.
        Arch Neurol. 2007; 64: 899-901
        • Galetta S.L.
        • Bennett J.
        Neuromyelitis optica is a variant of multiple sclerosis.
        Arch Neurol. 2007; 64: 901-903
        • Roach E.S.
        Is neuromyelitis optica a distinct entity?.
        Arch Neurol. 2007; 64: 906
        • Walsh M.J.
        • Tourtellotte W.W.
        Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis.
        J Exp Med. 1986; 163: 41-53
        • Takahashi T.
        • Fujihara K.
        • Nakashima I.
        • Misu T.
        • Miyazawa I.
        • Nakamura M.
        • et al.
        Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
        Brain. 2007; 130: 1235-1243
        • Kalluri S.R.
        • Illes Z.
        • Srivastava R.
        • Cree B.
        • Menge T.
        • Bennett J.L.
        • et al.
        Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica.
        Arch Neurol. 2010; 67: 1201-1208
        • West S.G.
        • Emlen W.
        • Wener M.H.
        • Kotzin B.L.
        Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests.
        Am J Med. 1995; 99: 153-163
        • Delalande S.
        • de Seze J.
        • Fauchais A.L.
        • Hachulla E.
        • Stojkovic T.
        • Ferriby D.
        • et al.
        Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients.
        Medicine Baltimore. 2004; 83: 280-291
        • Lucchinetti C.F.
        • Mandler R.N.
        • McGavern D.
        • Bruck W.
        • Gleich G.
        • Ransohoff R.M.
        • et al.
        A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.
        Brain. 2002; 125: 1450-1461
        • Waters P.
        • Jarius S.
        • Littleton E.
        • Leite M.I.
        • Jacob S.
        • Gray B.
        • et al.
        Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
        Arch Neurol. 2008; 65: 913-919
        • Jarius S.
        • Franciotta D.
        • Bergamaschi R.
        • Wildemann B.
        • Wandinger K.P.
        Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders.
        Clin Chem Lab Med. 2010; 48: 659-663
        • Jarius S.
        • Aboul-Enein F.
        • Waters P.
        • Kuenz B.
        • Hauser A.
        • Berger T.
        • et al.
        Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
        Brain. 2008; 131: 3072-3080
        • Jongen P.J.
        • Lamers K.J.
        • Doesburg W.H.
        • Lemmens W.A.
        • Hommes O.R.
        Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.
        J Neurol Neurosurg Psychiatry. 1997; 63: 446-451
        • Posner J.B.
        • Plum F.
        Independence of blood and cerebrospinal fluid lactate.
        Arch Neurol. 1967; 16: 492-496
        • Kleine T.O.
        • Baerlocher K.
        • Niederer V.
        • Keller H.
        • Reutter F.
        • Tritschler W.
        • et al.
        Diagnostic significance of lactate concentration in CSF in patients with meningitis (author's transl).
        Dtsch Med Wochenschr. 1979; 104: 553-557
        • Mandler R.N.
        • Davis L.E.
        • Jeffery D.R.
        • Kornfeld M.
        Devic's neuromyelitis optica: a clinicopathological study of 8 patients.
        Ann Neurol. 1993; 34: 162-168
        • de Seze J.
        • Stojkovic T.
        • Ferriby D.
        • Gauvrit J.Y.
        • Montagne C.
        • Mounier-Vehier F.
        • et al.
        Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile.
        J Neurol Sci. 2002; 197: 57-61
        • Collongues N.
        • Marignier R.
        • Zephir H.
        • Papeix C.
        • Blanc F.
        • Ritleng C.
        • et al.
        Neuromyelitis optica in France: a multicenter study of 125 patients.
        Neurology. 2010; 74: 736-742
        • Correale J.
        • Fiol M.
        Activation of humoral immunity and eosinophils in neuromyelitis optica.
        Neurology. 2004; 63: 2363-2370